VR Logo

Marksans Pharma Ltd. download report


Healthcare | Drugs & Pharma

Marksans Pharma Ltd. Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2021 Marksans Pharma Ltd. Annual Report Marksans Pharma Ltd. chairman speech Marksans Pharma Ltd. director's report Marksans Pharma Ltd. management discussion Marksans Pharma Ltd. corporate governance Marksans Pharma Ltd. auditor's report Marksans Pharma Ltd. account notes
2020 Marksans Pharma Ltd. Annual Report Marksans Pharma Ltd. chairman speech Marksans Pharma Ltd. director's report Marksans Pharma Ltd. management discussion Marksans Pharma Ltd. corporate governance Marksans Pharma Ltd. auditor's report Marksans Pharma Ltd. account notes
2019 Marksans Pharma Ltd. Annual Report Marksans Pharma Ltd. chairman speech Marksans Pharma Ltd. director's report Marksans Pharma Ltd. management discussion Marksans Pharma Ltd. corporate governance Marksans Pharma Ltd. auditor's report Marksans Pharma Ltd. account notes
2018 Marksans Pharma Ltd. Annual Report Marksans Pharma Ltd. chairman speech Marksans Pharma Ltd. director's report Marksans Pharma Ltd. management discussion Marksans Pharma Ltd. corporate governance Marksans Pharma Ltd. auditor's report Marksans Pharma Ltd. account notes
2017 Marksans Pharma Ltd. Annual Report Marksans Pharma Ltd. chairman speech Marksans Pharma Ltd. director's report Marksans Pharma Ltd. management discussion Marksans Pharma Ltd. corporate governance Marksans Pharma Ltd. auditor's report Marksans Pharma Ltd. account notes
2016 Marksans Pharma Ltd. Annual Report Marksans Pharma Ltd. chairman speech Marksans Pharma Ltd. director's report Marksans Pharma Ltd. management discussion Marksans Pharma Ltd. corporate governance Marksans Pharma Ltd. auditor's report Marksans Pharma Ltd. account notes
2015 Marksans Pharma Ltd. Annual Report Marksans Pharma Ltd. chairman speech Marksans Pharma Ltd. director's report Marksans Pharma Ltd. management discussion Marksans Pharma Ltd. corporate governance Marksans Pharma Ltd. auditor's report Marksans Pharma Ltd. account notes
2014 Marksans Pharma Ltd. Annual Report Marksans Pharma Ltd. chairman speech Marksans Pharma Ltd. director's report Marksans Pharma Ltd. management discussion Marksans Pharma Ltd. corporate governance Marksans Pharma Ltd. auditor's report Marksans Pharma Ltd. account notes
2013 Marksans Pharma Ltd. Annual Report Marksans Pharma Ltd. chairman speech Marksans Pharma Ltd. director's report Marksans Pharma Ltd. management discussion Marksans Pharma Ltd. corporate governance Marksans Pharma Ltd. auditor's report Marksans Pharma Ltd. account notes
2012 Marksans Pharma Ltd. Annual Report Marksans Pharma Ltd. chairman speech Marksans Pharma Ltd. director's report Marksans Pharma Ltd. management discussion Marksans Pharma Ltd. corporate governance Marksans Pharma Ltd. auditor's report Marksans Pharma Ltd. account notes
2011 Marksans Pharma Ltd. Annual Report Marksans Pharma Ltd. chairman speech Marksans Pharma Ltd. director's report Marksans Pharma Ltd. management discussion Marksans Pharma Ltd. corporate governance Marksans Pharma Ltd. auditor's report Marksans Pharma Ltd. account notes
2010 Marksans Pharma Ltd. Annual Report Marksans Pharma Ltd. chairman speech Marksans Pharma Ltd. director's report Marksans Pharma Ltd. management discussion Marksans Pharma Ltd. corporate governance Marksans Pharma Ltd. auditor's report Marksans Pharma Ltd. account notes
2009 Marksans Pharma Ltd. Annual Report Marksans Pharma Ltd. chairman speech Marksans Pharma Ltd. director's report Marksans Pharma Ltd. management discussion Marksans Pharma Ltd. corporate governance Marksans Pharma Ltd. auditor's report Marksans Pharma Ltd. account notes
2008 Marksans Pharma Ltd. Annual Report Marksans Pharma Ltd. chairman speech Marksans Pharma Ltd. director's report Marksans Pharma Ltd. management discussion Marksans Pharma Ltd. corporate governance Marksans Pharma Ltd. auditor's report Marksans Pharma Ltd. account notes
2007 Marksans Pharma Ltd. Annual Report Marksans Pharma Ltd. chairman speech Marksans Pharma Ltd. director's report Marksans Pharma Ltd. management discussion Marksans Pharma Ltd. corporate governance Marksans Pharma Ltd. auditor's report Marksans Pharma Ltd. account notes
2006 Marksans Pharma Ltd. Annual Report Marksans Pharma Ltd. chairman speech Marksans Pharma Ltd. director's report Marksans Pharma Ltd. management discussion Marksans Pharma Ltd. corporate governance Marksans Pharma Ltd. auditor's report Marksans Pharma Ltd. account notes
2005 Marksans Pharma Ltd. Annual Report Marksans Pharma Ltd. chairman speech Marksans Pharma Ltd. director's report Marksans Pharma Ltd. management discussion Marksans Pharma Ltd. corporate governance Marksans Pharma Ltd. auditor's report Marksans Pharma Ltd. account notes

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1992

Chairman: Mark Saldanha

Managing Director: Mark Saldanha

Listing: BSE: 524404, NSE: MARKSANS

Country: India

Headquarters: Mumbai, Maharashtra

Website: www.marksanspharma.com

Key Facts

Market cap: ₹1,743.68 Cr

Revenue (TTM): ₹1,490.84 Cr

Earnings (TTM): ₹186.81 Cr

Cash: ₹349.70 Cr

Total Debt: ₹18.74 Cr

Promoters' ownership: 48.25%

Liquidity: High

52 Week range: ₹38.60 - 93.60

Face value: ₹1.00

Shares outstanding: 40,93,13,698

10 Years Aggregate:

  • CFO: ₹730.03 Cr
  • EBITDA: ₹1,167.13 Cr
  • Net Profit: ₹627.94 Cr

Stock Performance

Time Period Marksans Pharma S&P BSE Healthcare S&P BSE Small Cap
YTD-29.09-17.06-15.25
1 month-8.67-3.28-2.56
3 months-14.01-10.69-10.20
1 Year-51.06-13.41-0.12
3 Years26.6419.0520.55
5 Years0.849.2310.52
10 Years40.7312.3914.50
As on 28-Jun-2022
Year Marksans Pharma S&P BSE Small Cap S&P BSE Healthcare
2021-1.3162.7720.87
2020253.6432.1161.45
2019-40.78-6.85-3.55
2018-30.29-23.41-5.89
20170.2559.640.49
2016-61.901.77-12.88
201566.326.7615.06